Voyager Therapeutics (VYGR) Non-cash Items (2015 - 2025)

Voyager Therapeutics has disclosed Non-cash Items across 11 years of filings, most recently posting $6.4 million for Q4 2025.

• Non-cash Items for Q4 2025 came in at $6.4 million, up 408.16% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.4 million (up 408.16% YoY), and the FY2025 annual result was $6.4 million, up 31.4% from the prior year.
• Non-cash Items came in at $6.4 million for Q4 2025 at Voyager Therapeutics, up from $6.0 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $17.9 million in Q1 2024 to a low of $247000.0 in Q2 2025.
• The 5-year median for Non-cash Items is $3.8 million (2021), against an average of $4.9 million.
• Across the five-year window, Non-cash Items jumped 709.58% in 2021 and tumbled 94.14% in 2025, its largest moves.
• Voyager Therapeutics' Non-cash Items stood at $1.2 million in 2021, then soared by 423.18% to $6.1 million in 2022, then sank by 37.27% to $3.8 million in 2023, then tumbled by 67.28% to $1.3 million in 2024, then soared by 408.16% to $6.4 million in 2025.
• The last three Non-cash Items figures came in at $6.4 million (Q4 2025), $6.0 million (Q3 2025), and $247000.0 (Q2 2025), per Business Quant data.